Drug safety notice: Ranitidine

October 17, 2019

All oral formulations of ranitidine are anticipated to be out of stock, with no date for resupply until further notice. This is due to the identification of a contaminant, N-nitrosodimethylamine (NDMA), in samples of ranitidine active substance.

Although all oral formulations are expected to be out of stock, very limited supplies of unaffected oral ranitidine products may remain available and should be reserved for those patients in whom alternatives are not clinically appropriate.

Please see Ranitidine sheet for details on managing the supply issue.

For more information please contact the pharmacy department on ext. 5259.